NO166788C - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner.

Info

Publication number
NO166788C
NO166788C NO883486A NO883486A NO166788C NO 166788 C NO166788 C NO 166788C NO 883486 A NO883486 A NO 883486A NO 883486 A NO883486 A NO 883486A NO 166788 C NO166788 C NO 166788C
Authority
NO
Norway
Prior art keywords
tetrahydrobenzofuro
pyridines
procedure
preparation
therapeutic active
Prior art date
Application number
NO883486A
Other languages
English (en)
Norwegian (no)
Other versions
NO883486L (no
NO166788B (no
NO883486D0 (no
Inventor
Mireille Sevrin
Pascal George
Claude Morel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO883486D0 publication Critical patent/NO883486D0/no
Publication of NO883486L publication Critical patent/NO883486L/no
Publication of NO166788B publication Critical patent/NO166788B/no
Publication of NO166788C publication Critical patent/NO166788C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO883486A 1987-08-07 1988-08-05 Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner. NO166788C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711287A FR2619112B1 (fr) 1987-08-07 1987-08-07 Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
NO883486D0 NO883486D0 (no) 1988-08-05
NO883486L NO883486L (no) 1989-02-08
NO166788B NO166788B (no) 1991-05-27
NO166788C true NO166788C (no) 1991-09-04

Family

ID=9354025

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883486A NO166788C (no) 1987-08-07 1988-08-05 Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner.

Country Status (17)

Country Link
US (1) US4931449A (de)
EP (1) EP0302787B1 (de)
JP (1) JPS6466187A (de)
KR (1) KR890003768A (de)
AT (1) ATE69054T1 (de)
AU (1) AU597187B2 (de)
DE (1) DE3865917D1 (de)
DK (1) DK437688A (de)
FI (1) FI883668A7 (de)
FR (1) FR2619112B1 (de)
GR (1) GR3003375T3 (de)
HU (1) HU201075B (de)
IL (1) IL87338A (de)
NO (1) NO166788C (de)
NZ (1) NZ225707A (de)
PT (1) PT88205B (de)
ZA (1) ZA885787B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3902372A1 (de) * 1989-01-27 1990-08-02 Hoechst Ag Verfahren zur herstellung von d((pfeil hoch)+(pfeil hoch))-2-(4-acetylphenoxy)- propionsaeureestern
FR2661178B1 (fr) * 1990-04-24 1993-03-12 Synthelabo Derives de [(tetrahydro-1,2,3,4 isoquinoleinyl-2)methyl]-4 piperidinecarboxylates-1 d'alkyle, leur preparation et leur application en therapeutique.
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
US8128257B2 (en) 2007-02-09 2012-03-06 Bright View Technologies Corporation Curved compact collimating reflectors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583307D1 (en) * 1984-05-10 1991-08-01 Ciba Geigy Ag Benzo-(pyrano und thiopyrano)-pyridine.
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate

Also Published As

Publication number Publication date
HUT47939A (en) 1989-04-28
DE3865917D1 (de) 1991-12-05
FR2619112B1 (fr) 1989-11-17
EP0302787B1 (de) 1991-10-30
EP0302787A1 (de) 1989-02-08
ATE69054T1 (de) 1991-11-15
US4931449A (en) 1990-06-05
PT88205A (pt) 1989-06-30
DK437688D0 (da) 1988-08-05
JPS6466187A (en) 1989-03-13
DK437688A (da) 1989-02-08
NO883486L (no) 1989-02-08
FI883668A0 (fi) 1988-08-05
ZA885787B (en) 1989-04-26
HU201075B (en) 1990-09-28
IL87338A (en) 1992-01-15
AU2044488A (en) 1989-02-09
FI883668L (fi) 1989-02-08
FR2619112A1 (fr) 1989-02-10
IL87338A0 (en) 1989-01-31
NO166788B (no) 1991-05-27
NZ225707A (en) 1989-11-28
AU597187B2 (en) 1990-05-24
KR890003768A (ko) 1989-04-18
NO883486D0 (no) 1988-08-05
FI883668A7 (fi) 1989-02-08
PT88205B (pt) 1995-05-04
GR3003375T3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
FI883249A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
NO2001003I1 (no) Gadovist
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
NO903911D0 (no) Fremgangsmaate for fremstilling av 4-hydroksytetrahydropyran-2-on og de tilsvarende dihydroksykarboksylsyrederivater, salter og estere, deres anvendelse som legemidler, farmasoeytiske preparater og forprodukter.
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
DK0435749T3 (da) 2-Aminopyrimidin-4-carboxamid-derivater, deres fremstilling og deres terapeutiske anvendelse
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
NO163331C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer.
MX9205461A (es) Solucion acuosa estable de esparfloxacina y metodopara su preparacion
DK0388298T3 (da) Azetidinylsubstituerede derivater af pyridoncarboxylsyrer, deres fremstilling og anvendelse som lægemidler
DK119188D0 (da) Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne
NO900342L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)akridin-7-karboxylsyrer og beslektede forbindelser.
NO883486L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
IL74800A (en) Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
NO175637C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO933521L (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-N-oksyder, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel
NZ223334A (en) Imidazo and triazolo-thiadiazine derivatives and pharmaceutical compositions
FI890173L (fi) Isoxazoler med nootropisk verkan.
ES2080445T3 (es) Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos.
DK0581797T3 (da) Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng
FI882863L (fi) Foerfarande foer framstaellning av substituerade imidazo (1,5-a) pyridinderivat.